Recent advances in genetics, genomics, and biotechnology could have devastating implications for
bioweapons and genetically engineered diseases. As such, these developments raise the question of
whether it makes sense to pull attention away from “classic” biothreat targets, in favor of more
technologically advanced options. Immediacy and ease of use may be determining factors.